We are live on ! Find out more
ADMS

Adamas Pharmaceuticals
ADMS

Delisted

ADMS was delisted on the 23rd of November, 2021.

Back to rankings

52 hedge funds and large institutions have $196M invested in Adamas Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

208% more capital invested

Capital invested by funds: $63.7M → $196M (+$133M)

200% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 7

150% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 6

18% more funds holding

Funds holding: 44 → 52 (+8)

Holders
52
Holders Change
+8
Holders Change %
+18.18%
% of All Funds
1.39%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
15
Increased
21
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$7.11M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$2.75M
3
GPP
Great Point Partners
Connecticut
+$2.59M
4
TC
TFS Capital
Pennsylvania
+$1.34M
5
EA
Emerald Advisers
Pennsylvania
+$1.21M

Top Sellers

Rank Fund Capital Flow
1
BS
Bow Street
New York
-$1.65M
2
BA
BlackRock Advisors
Delaware
-$1.46M
3
BG
BlackRock Group
United Kingdom
-$890K
4
BlackRock
BlackRock
New York
-$393K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$241K
Name Holding Trade Value Shares
Change 		Change in
Stake
MMC
1
MDV Management Company
California
$79.6M +$69.6M +4,584,014 New
CPH
2
C Partners Holding
Switzerland
$35M +$30.5M +2,012,128 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$34.6M +$7.11M +468,914 +31%
OTPPB
4
Ontario Teachers' Pension Plan Board
Ontario, Canada
$9.51M – – –
EA
5
Emerald Advisers
Pennsylvania
$4.17M +$1.21M +79,704 +50%
WSA
6
Wall Street Associates
California
$3.91M – – –
EMFAT
7
Emerald Mutual Fund Advisers Trust
Pennsylvania
$3.68M +$586K +38,654 +22%
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$3.27M +$2.75M +181,136 +2,524%
GPP
9
Great Point Partners
Connecticut
$2.97M +$2.59M +170,816 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$1.72M +$923K +60,857 +158%
State of New Jersey Common Pension Fund D
11
State of New Jersey Common Pension Fund D
New Jersey
$1.62M – – –
TC
12
TFS Capital
Pennsylvania
$1.53M +$1.34M +88,186 New
BFA
13
BlackRock Fund Advisors
California
$1.39M +$244K +16,072 +25%
JP Morgan Chase
14
JP Morgan Chase
New York
$1.22M +$874K +57,600 +461%
Alyeska Investment Group
15
Alyeska Investment Group
Illinois
$1.14M +$661K +43,537 +198%
SIM
16
Spark Investment Management
New York
$1.13M +$681K +44,900 +221%
GPCM
17
Granite Point Capital Management
Massachusetts
$1.07M – – –
NI
18
Numeric Investors
Massachusetts
$872K +$762K +50,224 New
PAM
19
Private Asset Management
California
$828K +$724K +47,690 New
Citadel Advisors
20
Citadel Advisors
Florida
$751K +$311K +20,475 +90%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$685K +$332K +21,877 +124%
SO
22
STRS Ohio
Ohio
$622K +$504K +33,204 +1,279%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$557K +$487K +32,095 New
Northern Trust
24
Northern Trust
Illinois
$548K -$5.43K -358 -1%
Morgan Stanley
25
Morgan Stanley
New York
$445K +$383K +25,224 +6,290%
1
2 3

ADMS Hedge Fund Activity: Q4 2014 in Review

52 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Adamas Pharmaceuticals (ADMS) for Q4 2014, worth a combined $196M — up 208% from $63.7M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ADMS positions and 6 closed out — a net gain of 9 holders — while 21 added to existing stakes and 7 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $7.11M. The largest seller was Bow Street, exiting entirely with an estimated $1.65M sold.

  • 52 institutional investors held Adamas Pharmaceuticals (ADMS) as of Q4 2014, up from 44 in Q3 2014.
  • Funds reported $196M of Adamas Pharmaceuticals stock for Q4 2014, up 208% quarter-over-quarter.
  • 15 funds opened new Adamas Pharmaceuticals positions in Q4 2014 and 6 closed out, a net change of +9 holders.
  • The largest Adamas Pharmaceuticals buyer in Q4 2014 was Fidelity Investments, an estimated $7.11M added.
  • The largest Adamas Pharmaceuticals seller in Q4 2014 was Bow Street, an estimated $1.65M sold.

Based on aggregated 13F filings for Q4 2014.